| Financial Year |
March 31 2023 |
| Monetary Funds |
2,168,763,412.66 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
205,660,426.32 |
| Advances to Suppliers |
13,775,511.07 |
| Other Receivables |
47,726,157.61 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
331,770,597.09 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
1,182,630.03 |
| Total Current Assets |
3,530,085,257.84 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
5,752,784,775.02 |
| Under-construction Projects |
255,608,816.68 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
8,971,713.95 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
196,455,819.95 |
| Deferred Income Tax Assets |
18,634,444.45 |
| Other Non-Current Assets |
2,260,028.85 |
| Sub-Total of Non-Current Assets |
7,018,643,380.64 |
| Total Assets |
10,548,728,638.48 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
421,127,356.21 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
98,241,230.97 |
| Taxes Payable |
57,265,933.97 |
| Interest Payable |
-- |
| Dividend Payable |
143,826.35 |
| Other payables |
22,259,214.51 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
570,776,531.82 |
| Other Current Liabilities |
266.90 |
| Sub-Total of Current Liabilities |
1,183,550,248.08 |
| Long-term Loans |
920,001,468.70 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
1,447,087,810.85 |
| Total Liabilities |
2,630,638,058.93 |
| Paid-In Capital(Or Share Stock) |
4,852,783,848.00 |
| Capital Surplus |
4,052,787,937.79 |
| Surplus Reserve |
106,866,753.73 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-1,242,521,281.17 |
| Minority Stockholder's Interest |
139,243,679.53 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
7,778,846,900.02 |
| Owner's Equity（Stockholder's Equity） |
7,918,090,579.55 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
10,548,728,638.48 |
